Differentiation and regeneration potential of mesenchymal progenitor cells derived from traumatized muscle tissue

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 11, 2011, Pages 2377-2388

  Jackson, Wesley M ^a   Lozito, Thomas P ^a,b   Djouad, Farida ^a   Kuhn, Nastaran Z ^a   Nesti, Leon J ^a,c   Tuan, Rocky S ^a,b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Immunoregulation; Mesenchymal stem cells; Progenitor cells; Regenerative medicine; Tissue engineering

Indexed keywords

ADIPOCYTE; ADULT; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; HUMAN; INJURY; MESENCHYMAL STEM CELL; METABOLISM; OSTEOBLAST; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; TISSUE ENGINEERING;

ADIPOCYTES; ADULT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; REGENERATION; TISSUE ENGINEERING;

EID: 80054956709     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01225.x     Document Type: Article

References (56)

1. Chen FH, Tuan RS. Adult stem cells for cartilage tissue engineering and regeneration. Curr Rhematol Rev. 2008; 4: 149-54.
2. Patterson TE, Kumagai K, Griffith L, et al Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am. 2008; 90: 111-9.
3. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2007; 15: 109-16.
4. Nesselmann C, Ma N, Bieback K, et al Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008; 12: 1795-810.
5. Garcia-Castro J, Trigueros C, Madrenas J, et al Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med. 2008; 12: 2552-65.
6. Newman RE, Yoo D, LeRoux MA, et al Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets. 2009; 8: 110-23.
7. Kuo CK, Tuan RS. Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag. 2003; 22: 51-6.
8. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009; 217: 318-24.
9. Tang YL, Zhao Q, Zhang YC, et al Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept. 2004; 117: 3-10.
10. Martens TP, See F, Schuster MD, et al Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med. 2006; 3: S18-22.
11. Li L, Zhang Y, Li Y, et al Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int. 2008; 21: 1181-9.
12. Kode JA, Mukherjee S, Joglekar MV, et al Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009; 11: 377-91.
13. Le Blanc K, Rasmusson I, Sundberg B, et al Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004; 363: 1439-41.
14. Habib NA, Gordon MY. Clinical applications of stem cell therapy - the pros and cons of stem cell sources. Regen Med. 2006; 1: 301-2.
15. Bongso A, Fong CY, Gauthaman K. Taking stem cells to the clinic: major challenges. J Cell Biochem. 2008; 105: 1352-60.
16. Zheng B, Cao B, Crisan M, et al Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol. 2007; 25: 1025-34.
17. Jackson WM, Aragon AB, Djouad F, et al Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med. 2009; 3: 129-38.
18. Crisan M, Yap S, Casteilla L, et al A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008; 3: 301-13.
19. Nesti LJ, Jackson WM, Shanti RM, et al Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am. 2008; 90: 2390-8.
20. Jackson WM, Aragon AB, Bulken-Hoover JD, et al Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res. 2009; 27: 1645-51.
21. Grefte S, Kuijpers-Jagtman AM, Torensma R, et al Skeletal muscle development and regeneration. Stem Cells Dev. 2007; 16: 857-68.
22. Bianco P, Robey P, Simmons P. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2: 313-9.
23. Pountos I, Giannoudis PV. Biology of mesenchymal stem cells. Injury. 2005; 36: S8-S12.
24. Caterson EJ, Nesti LJ, Danielson KG, et al Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol. 2002; 20: 245-56.
25. Djouad F, Jackson WM, Bobbick BE, et al Activin A expression regulates multipotency of mesenchymal progenitor cells. Stem Cell Res Ther. 2010; 1: 11-23.
26. Ades EW, Candal FJ, Swerlick RA, et al HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 1992; 99: 683-90.
27. Xu Y, Swerlick RA, Sepp N, et al Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol. 1994; 102: 833-7.
28. Lozito TP, Taboas JM, Kuo CK, et al Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. J Cell Biochem. 2009; 107: 706-13.
29. Dominici M, Le Blanc K, Mueller I, et al Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
30. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999; 181: 67-73.
31. Muschler GF, Nitto H, Boehm CA, et al Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001; 19: 117-25.
32. Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow. Bone. 1992; 13: 81-8.
33. Attinger CE, Bulan E, Blume PA. Surgical debridement. The key to successful wound healing and reconstruction. Clin Podiatr Med Surg. 2000; 17: 599-630.
34. Jiang Y, Mishima H, Sakai S, et al Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders. J Orthop Res. 2008; 26: 910-7.
35. Crisostomo PR, Wang M, Herring CM, et al Sex dimorphisms in activated mesenchymal stem cell function. Shock. 2006; 26: 571-4.
36. Crisostomo PR, Markel TA, Wang M, et al In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery. 2007; 142: 215-21.
37. Fehrer C, Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol. 2005; 40: 926-30.
38. Ray R, Novotny NM, Crisostomo PR, et al Sex steroids and stem cell function. Mol Med. 2008; 14: 493-501.
39. Madonna R, Renna FV, Cellini C, et al Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells. Eur J Clin Invest. 2010; 41: 126-33.
40. Zhou S, Greenberger JS, Epperly MW, et al Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008; 7: 335-43.
41. Crisan M, Deasy B, Gavina M, et al Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol. 2008; 86: 295-309.
42. Okamoto T, Aoyama T, Nakayama T, et al Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun. 2002; 295: 354-61.
43. Qu-Petersen Z, Deasy B, Jankowski R, et al Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol. 2002; 157: 851-64.
44. Gharaibeh B, Lu A, Tebbets J, et al Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc. 2008; 3: 1501-9.
45. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9: 204.
46. Battula VL, Evans KW, Hollier BG, et al Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells. 2010; 28: 1435-45.
47. Corselli M, Chen CW, Crisan M, et al Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol. 2010; 30: 1104-9.
48. Tondreau T, Meuleman N, Delforge A, et al Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005; 23: 1105-12.
49. Siggins RW, Zhang P, Welsh D, et al Stem cells, phenotypic inversion, and differentiation. Int J Clin Exp Med. 2008; 1: 2-21.
50. Levesque JP, Takamatsu Y, Nilsson SK, et al Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood. 2001; 98: 1289-97.
51. Fukada S, Yamamoto Y, Segawa M, et al CD90-positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy(3k)/dy(3k) mice. Exp Cell Res. 2008; 314: 193-203.
52. Cizkova D, Soukup T, Mokry J. Nestin expression reflects formation, revascularization and reinnervation of new myofibers in regenerating rat hind limb skeletal muscles. Cells Tissues Organs. 2009; 189: 338-47.
53. Caplan AI. New era of cell-based orthopaedic therapies. Tissue Eng Part B Rev. 2009; 15: 195-200.
54. Jackson WM, Nesti LJ, Tuan RS. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther. 2010; 10: 1-13.
55. Bulken-Hoover JD, Jackson WM, Zambrano I, et al Optimization of neurotrophic factor production in mesenchymal stem and progenitor cells. Mol Biotechnol. 2010; Under Review.
56. Zhang X, Jiao C, Zhao S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev. 2009; 5: 402-9.